See also this year's filing and all EDGAR filings for this company.
PDF Report 0001730430_2023_Kiniksa_Pharmaceuticals_International_plc.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 5.279451438848921, 'aggregate_val': 38070000, 'exp_sum': -8896000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 97951000, 'ResearchAndDevelopmentExpense': 65490000, 'remainder_Expenses': -172337000}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.5145147264114242, 'aggregate_val': 264719000, 'exp_sum': 174788000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 129427000, 'ResearchAndDevelopmentExpense': 76097000, 'remainder_Expenses': -30736000}} |
Graph
Absolute values for 0001730430, Kiniksa Pharmaceuticals International plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 243,060,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 18,250,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,658,000 |
| 3 | remainder_Assets | 196,704,000 |
| 4 | LiabilitiesCurrent | 47,066,000 |
| 5 | LiabilitiesNoncurrent | 16,457,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 8,882,894 |
| 8 | SellingGeneralAndAdministrativeExpense | 112,194,056 |
| 9 | ResearchAndDevelopmentExpense | 46,492,870 |
| 10 | remainder_Expenses | -754,969,857 |
| 11 | remainder_Revenues | 1,135,542,104 |
| 12 | remainder_NetIncome | -10,801 |
| 13 | remainder_ComprehensiveNetIncome | 83,857 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 459,672,000 |
| 1 | Liabilities | 63,523,000 |
| 2 | Expenses | -587,400,037 |
| 3 | Revenues | 1,135,542,104 |
| 4 | StockholdersEquity | 396,149,000 |
| 5 | NetIncome | 1,722,931,340 |
| 6 | ComprehensiveNetIncome | 1,722,973,268 |
| 7 | BaseVar | 1,123,115,900 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 9.89 |
| 9 | EconomicCapitalRatio | 9.89 |
Edgar->Model Mapping
Feature Distribution
Change over Time
